Results per Page:
Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’
Fred Hutch Cancer Center clinicians recognized as Seattle Met Magazine’s 2024 Top Doctors
Over 80 physicians, physician assistants and nurse practitioners named in annual list
Pinpointing pain: Is it cancer or cancer treatment?
Distinguishing side effects of treatment from a potential metastatic recurrence can be tricky; we asked cancer experts for their best advice
Racial inequalities in prostate cancer treatment among Medicare beneficiaries
From Dr. Yaw Nyame, Fred Hutch Public Health Sciences Division and the University of Washington
Bringing science and better health outcomes to all
Fred Hutch’s Pathways to Equity Symposium: Heartbreaking statistics, hopeful plans, and recognition for a pair of health-equity trailblazers
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment